Further studies are now required to determine the functional role of MRP2 in limiting tumour cell accumulation of platinum and sensitivity to oxaliplatin, and the therapeutic potential of targeting MRP2 as a strategy for re-sensitizing resistant tumours to chemotherapy [51]. Here, ABCC2 is linked to neoplasm.